Skip to main content

20 May 2024

Last updated: Friday 10 May 2024

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
A New Start For An Amyloidosis Therapy

A new start for an amyloidosis therapy

Sunday 8 August 2021

Interviewee/Contributor

Pierre Vandepapelière

Organisation

Amyl Therapeutics BV

---Subscribe to MedNous to access this article---

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Laverock Therapeutics names finance director

Thursday 2 May 2024

neurocare appoints VP Europe and Latin America

Thursday 2 May 2024

Nxera Pharma appoints Japan business development head

Thursday 2 May 2024

Transgene makes two promotions to senior positions

Thursday 2 May 2024

Galapagos appoints Gilead CFO to board

Thursday 2 May 2024

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2024 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form